Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Acrivon AB
AB
Active
Org 5591520944
Lund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 8 years old
13 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Acrivon AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
KJ
Karl John Christian Karlsson
Authorized Recipient of Service
Authorized Recipient of Service
2025
KM
Kristina Marianne Masson
Chief Executive Officer
Chief Executive Officer
2025
CA
Curt Arne Jesper Ahlkvist
Audit
Audit
2022
Former (1)
AH
Annika Heléne Lundeslöf
Authorized Recipient of Service
Authorized Recipient of Service
2023 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
MC
Marcin Czernik
Deputy Board Member
Deputy Board Member
2022
PB
Peter Blume-Jensen
Board of Directors
Board of Directors
2022
KM
Kristina Marianne Masson
Chairman
Chairman
2022
Shareholders
As of last annual report
ACRIVON THERAPEUTICS INC — 100%
100%
Shareholder
Type
Ownership
Votes
Since
ACRIVON THERAPEUTICS INC
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Acrivon AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network